Edwards Lifesciences Corporation EW

Company Overview

Edwards Lifesciences Corporation is a global medical technology company focused on the development and manufacture of innovative therapies for structural heart disease and advanced hemodynamic monitoring. The company operates primarily within the medical devices and cardiovascular healthcare industries, serving hospitals, cardiac centers, and intensive care units worldwide. Its core mission centers on improving patient outcomes through minimally invasive and data-driven cardiovascular solutions.

The company’s primary revenue drivers are its Transcatheter Heart Valve Therapy products, particularly transcatheter aortic valve replacement (TAVR) systems, and its Critical Care monitoring platforms. Edwards Lifesciences is widely recognized for its leadership position in TAVR technology, supported by strong clinical evidence, physician training infrastructure, and long-term hospital relationships. The company was founded in 1958 and evolved significantly after being spun off from Baxter International in 2000, subsequently focusing its strategy exclusively on cardiovascular innovation.